Libido changes often occur during rapid dose escalation
GLP-1 Receptor Agonists, Obesity, and Cardiovascular Disease Glucagon-like peptide-1 receptor agonists (GLP-1RAs) were originally developed to improve glycemic control in type 2 diabetes but have since demonstrated benefits in weight reduction and cardiovascular risk modification, including in people without diabetes
14 These AEs can significantly impact a patients quality of life, leading to decreased adherence, limitation of dose escalations, and, in some cases, treatment discontinuation
Novo Nordisk added warning labels about gallbladder complications to the drug in March 2022
From this research and understanding the relationship between supplemented choline and carnitine, and increasing carnitine levels in the body for the purpose of a more favorable fat-burning environment, we realized everyone taking these carnitine-only products were really wasting their money, and all of these products could have been formulated properly had the research been done